Key terms
About TEVA
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TEVA news
Apr 22
7:15pm ET
Vanda Pharmaceuticals responds to U.S. Supreme Court denial of petition
Apr 19
6:14am ET
Alvotech signs agreement with Teva to bring Adalimumab-ryvk to U.S. market
Apr 19
6:13am ET
Alvotech signs agreement with Teva to bring Adalimumab-ryvk to U.S. market
Apr 18
4:23pm ET
Teva Pharmaceutical Revamps Financial Reporting Structure
Apr 16
5:32pm ET
Teva and Alvotech announce FDA approved SELARSDI injection
Apr 16
8:13am ET
Teva announces final results from the HD cohort study for Austedo at AAN
Apr 11
1:36pm ET
Pfizer (NYSE:PFE) Settlement Sends Shares Up Slightly
Apr 11
8:41am ET
Teva announces AJOVY study met all critical efficacy endpoints in China trial
Apr 07
6:31am ET
Teva presents eight studies from LAI schizophrenia research program
Apr 05
3:25am ET
Barclays Reaffirms Their Buy Rating on Teva Pharmaceutical (TEVA)
Apr 04
3:36pm ET
Teva put volume heavy and directionally bearish
Apr 04
8:39am ET
Teva Pharmaceuticals, mAbxience announce strategic global agreement
Apr 01
8:33am ET
Teva, Launch Therapeutics enter clinical collaboration agreement
Mar 08
9:40am ET
GE upgraded, Vail Resorts downgraded: Wall Street’s top analyst calls
Mar 08
7:10am ET
Teva upgraded to Neutral from Underweight at JPMorgan
Mar 04
9:27am ET
UBS confident in Teva’s continued growth trajectory
Feb 26
7:55am ET
Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
Feb 26
7:12am ET
Teva, Jiangsu Nhwa Pharmaceutical enter partnership
Feb 25
6:23am ET
Alvotech, Teva announce U.S. approval of SIMLANDI injection
Feb 20
10:35am ET
Teva put volume heavy and directionally bearish
Feb 20
9:09am ET
Teva presents data confirming target engagement o TEV-‘574 at ECCO meeting
Feb 13
1:00am ET
Teva Pharmaceutical Industries Limited Is Worried About This – Should You Be Worried Too?
Feb 12
9:47am ET
Teva rises 5.2%
Feb 12
5:04am ET
Teva upgraded to Overweight from Neutral at Piper Sandler
Feb 12
5:02am ET
Analysts Offer Insights on Healthcare Companies: India Globalization Capital (IGC), Tango Therapeutics (TNGX) and Teva Pharmaceutical (TEVA)
Feb 05
7:30am ET
Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (OtherSEMHF), Teva Pharmaceutical (TEVA) and ACADIA Pharmaceuticals (ACAD)
Feb 05
5:46am ET
Teva price target raised to $17 from $15 at Barclays
Feb 05
2:56am ET
Barclays Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
Feb 05
12:05am ET
Goldman Sachs Sticks to Its Hold Rating for Teva Pharmaceutical (TEVA)
Feb 01
7:39am ET
Teva price target raised to $16 from $15 at UBS
Feb 01
4:25am ET
UBS Remains a Buy on Teva Pharmaceutical (TEVA)
No recent press releases are available for TEVA
TEVA Financials
Key terms
Ad Feedback
TEVA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TEVA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range